These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 8956336)
1. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Yeh MK; Davis SS; Coombes AG Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336 [TBL] [Abstract][Full Text] [Related]
2. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. Morlock M; Kissel T; Li YX; Koll H; Winter G J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434 [TBL] [Abstract][Full Text] [Related]
4. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421 [TBL] [Abstract][Full Text] [Related]
5. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Coombes AG; Yeh MK; Lavelle EC; Davis SS J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451 [TBL] [Abstract][Full Text] [Related]
6. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512 [TBL] [Abstract][Full Text] [Related]
8. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
9. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. Takahata H; Lavelle EC; Coombes AG; Davis SS J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer. Lee KE; Kim BK; Yuk SH Biomacromolecules; 2002; 3(5):1115-9. PubMed ID: 12217061 [TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973 [TBL] [Abstract][Full Text] [Related]
14. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization. Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618 [TBL] [Abstract][Full Text] [Related]
15. The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility. McGee JP; Singh M; Li XM; Qiu H; O'Hagan DT J Microencapsul; 1997; 14(2):197-210. PubMed ID: 9132471 [TBL] [Abstract][Full Text] [Related]
16. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cho SW; Song SH; Choi YW Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588 [TBL] [Abstract][Full Text] [Related]